Skip to main content

Betamimetics and Placental Insufficiency Due to Uterine Hypoplasia

  • Conference paper
Therapy of Feto-Placental Insufficiency
  • 44 Accesses

Abstract

The action mechanism of the betamimetics has been researched by ROBINSON, BUCHER and SUTHERLAND at the level of the cardiovascular system; intracellular adenyl-cyclase is activated. This enzyme catalyses ATP into AMPc, increased membrane potential hence increasing the threshold of excitability and inhibiting contractions. Similar effects occur in the uterus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Gardey, G., Serrano, J.J., Viala, J.L. (1975). Betamimetics and Placental Insufficiency Due to Uterine Hypoplasia. In: Salvadori, B. (eds) Therapy of Feto-Placental Insufficiency. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66008-5_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66008-5_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66010-8

  • Online ISBN: 978-3-642-66008-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics